Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for ABVC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 25.77M
March 31, 2026 25.77M
December 31, 2025 25.05M
September 30, 2025 24.19M
June 30, 2025 19.53M
March 31, 2025 15.38M
December 31, 2024 13.87M
September 30, 2024 12.71M
June 30, 2024 12.05M
March 31, 2024 10.70M
December 31, 2023 7.940M
September 30, 2023 4.823M
June 30, 2023 3.280M
March 31, 2023 3.280M
December 31, 2022 3.286M
September 30, 2022 3.236M
June 30, 2022 3.231M
March 31, 2022 3.031M
September 30, 2021 2.794M
June 30, 2021 2.447M
March 31, 2021 2.442M
December 31, 2020 2.414M
September 30, 2020 2.039M
June 30, 2020 1.949M
March 31, 2020 1.949M
Date Value
December 31, 2019 1.920M
September 30, 2019 1.948M
June 30, 2019 1.812M
March 31, 2019 1.769M
December 31, 2018 1.161M
September 30, 2018 1.188M
June 30, 2018 1.188M
March 31, 2018 1.188M
December 31, 2017 1.188M
September 30, 2017 1.188M
June 30, 2017 1.188M
December 31, 2016 1.171M
September 30, 2016 1.171M
June 30, 2016 1.163M
March 31, 2016 1.160M
December 31, 2015 1.142M
September 30, 2015 1.047M
June 30, 2015 0.0002M
March 31, 2015 0.0002M
December 31, 2014 0.0002M
September 30, 2014 0.0002M
June 30, 2014 0.0002M
March 31, 2014 0.0002M
December 31, 2013 0.0002M
September 30, 2013 0.0002M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Anika Therapeutics, Inc. 13.38M
Perspective Therapeutics, Inc. 114.09M
MiMedx Group, Inc. 145.72M
Abbott Laboratories 1.730B
AngioDynamics, Inc. 41.70M